1-1050520-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_198576.4(AGRN):​c.5070C>T​(p.Phe1690Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0132 in 1,612,818 control chromosomes in the GnomAD database, including 722 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.042 ( 372 hom., cov: 33)
Exomes 𝑓: 0.010 ( 350 hom. )

Consequence

AGRN
NM_198576.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.29

Publications

5 publications found
Variant links:
Genes affected
AGRN (HGNC:329): (agrin) This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
AGRN Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 8
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 1-1050520-C-T is Benign according to our data. Variant chr1-1050520-C-T is described in ClinVar as Benign. ClinVar VariationId is 128313.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.29 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.127 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGRNNM_198576.4 linkc.5070C>T p.Phe1690Phe synonymous_variant Exon 29 of 36 ENST00000379370.7 NP_940978.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGRNENST00000379370.7 linkc.5070C>T p.Phe1690Phe synonymous_variant Exon 29 of 36 1 NM_198576.4 ENSP00000368678.2
AGRNENST00000651234.1 linkc.4755C>T p.Phe1585Phe synonymous_variant Exon 28 of 38 ENSP00000499046.1
AGRNENST00000652369.2 linkc.4755C>T p.Phe1585Phe synonymous_variant Exon 28 of 35 ENSP00000498543.1
AGRNENST00000620552.4 linkc.4656C>T p.Phe1552Phe synonymous_variant Exon 29 of 39 5 ENSP00000484607.1

Frequencies

GnomAD3 genomes
AF:
0.0417
AC:
6345
AN:
152100
Hom.:
369
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.130
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.0188
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00538
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00813
Gnomad OTH
AF:
0.0330
GnomAD2 exomes
AF:
0.0147
AC:
3658
AN:
248502
AF XY:
0.0121
show subpopulations
Gnomad AFR exome
AF:
0.131
Gnomad AMR exome
AF:
0.0113
Gnomad ASJ exome
AF:
0.00361
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00121
Gnomad NFE exome
AF:
0.00858
Gnomad OTH exome
AF:
0.0125
GnomAD4 exome
AF:
0.0102
AC:
14882
AN:
1460600
Hom.:
350
Cov.:
34
AF XY:
0.00974
AC XY:
7075
AN XY:
726644
show subpopulations
African (AFR)
AF:
0.135
AC:
4518
AN:
33478
American (AMR)
AF:
0.0125
AC:
559
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00368
AC:
96
AN:
26110
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.00364
AC:
314
AN:
86250
European-Finnish (FIN)
AF:
0.00134
AC:
70
AN:
52348
Middle Eastern (MID)
AF:
0.0172
AC:
99
AN:
5758
European-Non Finnish (NFE)
AF:
0.00744
AC:
8269
AN:
1111890
Other (OTH)
AF:
0.0159
AC:
957
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
985
1970
2956
3941
4926
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
370
740
1110
1480
1850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0418
AC:
6366
AN:
152218
Hom.:
372
Cov.:
33
AF XY:
0.0403
AC XY:
3003
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.130
AC:
5403
AN:
41514
American (AMR)
AF:
0.0187
AC:
286
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00538
AC:
26
AN:
4830
European-Finnish (FIN)
AF:
0.000659
AC:
7
AN:
10618
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00813
AC:
553
AN:
67992
Other (OTH)
AF:
0.0326
AC:
69
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
294
587
881
1174
1468
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0227
Hom.:
132
Bravo
AF:
0.0471
Asia WGS
AF:
0.0120
AC:
43
AN:
3478
EpiCase
AF:
0.00992
EpiControl
AF:
0.0109

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 26, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 29, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Congenital myasthenic syndrome 8 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
0.49
DANN
Benign
0.86
PhyloP100
-1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17160776; hg19: chr1-985900; COSMIC: COSV65070081; COSMIC: COSV65070081; API